
|Slideshows|June 21, 2019
FDA approvals you might have missed
Author(s)Miranda Hester
A look at 5 recent approvals from the US Food and Drug Administration (FDA), including treatment for systemic lupus erythematosus, a new gene therapy, and pain relief for patients with irritable bowel syndrome.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP issues guidance on providing medical care to parents during pediatric visits
2
AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older
3
Jeffrey Segar, MD, highlights sodium supplementation to support infant weight gain
4
Arcutis reports positive phase 2 data for roflumilast cream (Zoryve) in infants with atopic dermatitis
5






